Immunome Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | +111.5% | -35.5% | -23.2% | |
| – | +18.0% | +22.8% | +0.0% | -16.4% | +15.4% | +188.7% | +40.6% | |
| – | – | – | – | – | – | -35.5% | -55.9% | |
| – | +28.3% | -15.2% | +88.5% | +64.9% | -0.8% | +461.1% | +34.6% | |
| – | +76.1% | +213.1% | +132.3% | +22.9% | +44.2% | +67.7% | +32.8% | |
| – | +33.6% | +18.5% | +105.6% | +46.4% | +234.8% | +154.8% | -30.7% | |
| – | – | – | – | – | – | – | – | |
| – | -24.8% | -64.2% | -73.7% | -50.0% | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | +171.8% | -776.4% | – | – | -9.2% | -52,405.0% | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.